FibroScan and Liver Elastography are groundbreaking, non-invasive tests that measure liver stiffness (fibrosis) and fat content (steatosis) without needles or biopsies. At Liver Surgeons, Delhi’s premier center, we use these technologies to:
Non-Invasive Liver Fibrosis Assessment, CAP Score for Fat Quantification, and Monitoring Cirrhosis with 95% Accuracy
Aspect | FibroScan | Liver Biopsy |
---|---|---|
Invasiveness | Non-invasive, no needles | Invasive, requires tissue sample |
Risks | Zero complications | Bleeding, pain (1-2% risk) |
Accuracy | 90-95% for advanced fibrosis | Gold standard but sampling error |
Cost | Affordable, repeatable | Higher cost, longer recovery |
Ideal for patients needing non-invasive liver fibrosis assessment or avoiding biopsy risks.
Mr. Gupta’s Fatty Liver Reversal:
“My CAP score dropped from 320 to 250 in 6 months with diet changes guided by Dr. Ashish George’s Delhi team. No pills, just FibroScan monitoring!”
Ms. Reddy’s Cirrhosis Management:
“FibroScan detected early cirrhosis from hepatitis C. Dr. George’s antiviral plan reversed fibrosis – now my stiffness is normal!”
Fast for 3 hours. Wear comfortable clothing. No sedation or needles required.
No, but it identifies cirrhosis (a cancer risk factor). Pair with ultrasound for screening.
Yes! It uses harmless vibrations, not radiation.
Every 6–12 months to monitor cirrhosis progression or fatty liver.
FibroScan offers 90–95% accuracy for detecting advanced fibrosis/cirrhosis. Dr. Ashish George’s Delhi team pairs it with clinical data for non-invasive liver fibrosis assessment, matching biopsy reliability.
Yes! It provides a stiffness measurement (fibrosis) and CAP score (fat quantification) in one session – a hallmark of Dr. George’s advanced FibroScan in India.
Ideal for chronic hepatitis, fatty liver (MASLD), and alcohol-related disease. Rare cases (e.g., focal lesions) may need biopsy, assessed by Dr. George’s India team.
Dr. Ashish George’s Delhi center creates tailored plans – lifestyle changes, medications, or monitoring cirrhosis progression via repeat scans every 6 months.